Quorum Health EBITDA Margin 2014-2020 | QHCQQ
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Quorum Health (QHCQQ) over the last 10 years. The current EBITDA margin for Quorum Health as of March 31, 2020 is .
| Quorum Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2020-03-31 | $1.59B | $-0.01B | -0.88% |
| 2019-12-31 | $1.69B | $0.03B | 1.72% |
| 2019-09-30 | $1.76B | $0.04B | 2.38% |
| 2019-06-30 | $1.81B | $0.06B | 3.49% |
| 2019-03-31 | $1.84B | $0.05B | 2.94% |
| 2018-12-31 | $1.88B | $0.00B | -0.16% |
| 2018-09-30 | $1.94B | $-0.03B | -1.50% |
| 2018-06-30 | $1.97B | $0.00B | 0.05% |
| 2018-03-31 | $2.03B | $0.00B | -0.10% |
| 2017-12-31 | $2.07B | $0.07B | 3.38% |
| 2017-09-30 | $2.07B | $0.03B | 1.35% |
| 2017-06-30 | $2.12B | $0.05B | 2.36% |
| 2017-03-31 | $2.12B | $-0.20B | -9.35% |
| 2016-12-31 | $2.14B | $-0.17B | -7.90% |
| 2016-09-30 | $2.18B | $-0.07B | -3.35% |
| 2016-06-30 | $2.18B | $-0.07B | -3.12% |
| 2016-03-31 | $2.19B | $0.22B | 10.05% |
| 2015-12-31 | $2.19B | $0.23B | 10.70% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.000B |
| Quorum Health Corporation provides hospital and outpatient healthcare services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR). It operates QHR, which is a hospital management advisory and consulting services that provides services to non-affiliated general acute care hospitals. Its hospitals and its affiliated businesses offer services, such as general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetric, diagnostic, psychiatric, and rehabilitation services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |